Van Herk Groep
Van Herk Group, established in 1951 and based in the Netherlands, is an investment firm that manages diversified investment portfolios across various sectors. The firm focuses on real estate investments, including homes, shopping centers, offices, and industrial properties, primarily in the Benelux region. Additionally, Van Herk engages in direct investments in both listed and unlisted companies, with a particular emphasis on biotechnology, construction, financial services, and energy. For publicly traded companies, the firm explores opportunities globally, while its private investments typically target enterprises with an initial value ranging from €10 million to €150 million. Through these strategies, Van Herk Group aims to optimize its investment returns across multiple industries.
SkylineDx B.V. is a biotechnology company based in Rotterdam, the Netherlands, specializing in the development and commercialization of gene signature-based diagnostic tests aimed at personalizing treatment in oncology. The company focuses on molecular diagnostics for blood cancers, offering tools such as the AMLprofiler, which identifies subtypes of Acute Myeloid Leukemia, and the MMprofiler, a microarray-based service for diagnosing Multiple Myeloma. These diagnostics assist healthcare professionals in making informed therapy decisions tailored to individual patients. SkylineDx collaborates with academic, pharmaceutical, and industrial partners to advance the development of companion diagnostics and other related tests. The company was founded in 2005 and was previously known as Skyline Diagnostics B.V. before rebranding in 2013.
SkylineDx B.V. is a biotechnology company based in Rotterdam, the Netherlands, specializing in the development and commercialization of gene signature-based diagnostic tests aimed at personalizing treatment in oncology. The company focuses on molecular diagnostics for blood cancers, offering tools such as the AMLprofiler, which identifies subtypes of Acute Myeloid Leukemia, and the MMprofiler, a microarray-based service for diagnosing Multiple Myeloma. These diagnostics assist healthcare professionals in making informed therapy decisions tailored to individual patients. SkylineDx collaborates with academic, pharmaceutical, and industrial partners to advance the development of companion diagnostics and other related tests. The company was founded in 2005 and was previously known as Skyline Diagnostics B.V. before rebranding in 2013.
Sensara B.V., based in Rotterdam, the Netherlands, specializes in home healthcare equipment and software through its product Sensara HomeCare. The company aims to empower senior citizens and vulnerable individuals to maintain their independence while ensuring their safety and well-being. Sensara utilizes self-learning algorithms to monitor medically verified profiles, analyzing data from various sensors and providing alerts, signals, and advice to family members or caregivers as needed. The information is accessible through user-friendly apps and interfaces, allowing clients to have control over their own data and privacy. Sensara's modular product line offers comprehensive solutions that cater to different living environments, from independent and assisted living to nursing homes, with the goal of enhancing care based on historical data.
SkylineDx B.V. is a biotechnology company based in Rotterdam, the Netherlands, specializing in the development and commercialization of gene signature-based diagnostic tests aimed at personalizing treatment in oncology. The company focuses on molecular diagnostics for blood cancers, offering tools such as the AMLprofiler, which identifies subtypes of Acute Myeloid Leukemia, and the MMprofiler, a microarray-based service for diagnosing Multiple Myeloma. These diagnostics assist healthcare professionals in making informed therapy decisions tailored to individual patients. SkylineDx collaborates with academic, pharmaceutical, and industrial partners to advance the development of companion diagnostics and other related tests. The company was founded in 2005 and was previously known as Skyline Diagnostics B.V. before rebranding in 2013.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.